UK Earnings, Trading Statements Calendar | |
Thursday, September 24 | |
Good Energy | Half Year Results |
SVG Capital | Trading Statement |
Thomas Cook | Trading Statement |
Daily Mail and General Trust | Trading Statement |
Air Partner | Half Year Results |
WS Atkins | Trading Statement |
Haynes Publishing | Full Year Results |
hVIVO | Half Year Results |
Euromoney Institutional Investor | Trading Statement |
Dolphin Capital Investors | Half Year Results |
Friday, September 25 | |
Judges Scientific | Half Year Results |
CVS Group | Full Year Results |
Monday, September 28 | |
MJ Gleeson | Full Year Results |
Filtronic | Full Year Results |
Camco Clean Energy | Half Year Results |
Max Petroleum | Full Year Results |
Tuesday, September 29 | |
Vernalis | Full Year Results |
MySale Group | Full Year Results |
Moss Bros | Half Year Results |
Silence Therapeutics | Half Year Results |
Personal Group Holdings | Half Year Results |
Globo | Half Year Results |
Wolseley | Full Year Results |
James Halstead | Full Year Results |
Boohoo.com | Half Year Results |
Earthport | Full Year Results |
Revolution Bars | Half Year Results |
Outsourcery | Half Year Results |
SCS Group | Full Year Results |
People's Operator | Half Year Results |
Wednesday, September 30 | |
Topps Tiles | Trading Update |
Velocys | Half Year Results |
Graphene Nanochem | Half Year Results |
InternetQ | Half Year Results |
London Finance & Investment Group | Full Year Results |
Saga | Half Year Results |
Harvey Nash | Half Year Results |
Witan Pacific Investment Trust | Half Year Results |
Zanaga Iron Ore | Half Year Results |
J Sainsbury | Q2 Trading Statement |
Wizz Air Holdings | Half Year Results |
ServicePower Technologies | Half Year Results |
Copyright 2015 Alliance News Limited. All Rights Reserved. |
![ShareCast](https://static.lse.co.uk/images/news-logos/sharecast-news-logo.png)
Positive results from FLU-v study welcomed by hVIVO
(Sharecast News) - Clinical development services company hVIVO announced positive results for the primary endpoint, following completion of analysis of samples by NIAID, and additional results from the Phase IIb viral challenge study of FLU-v.
Read more